The Apothecary (W & C), Sartell, MN
Is The Apothecary (W & C) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does The Apothecary (W & C) hold a Minnesota pharmacy license?
State board of pharmacy records for Minnesota are not checked: the board’s website answers automated requests with a bot challenge, and this index does not work around blocks.
Has The Apothecary (W & C) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Oct 22, 2019), 1 state referral letter (Oct 22, 2019) and 1 FMD-145 letter (Oct 22, 2019) for The Apothecary (W & C). State board of pharmacy records for Minnesota are not checked: the board’s website answers automated requests with a bot challenge, and this index does not work around blocks. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- W & C; The Apothecary
- Location
- Sartell, MN
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Oct 22, 2019
- FDA Data Dashboard inspections
- 1 inspection: 1 OAI; 2 published Form 483s
- Form 483 text on this page
- 1 Form 483, 1 observation
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as W & C (dba The Apothecary), a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Oct 22, 2019 | Warning letter close-out | Warning Letter Close Out Issued 10/22/2019 | Not linked by FDA |
| Oct 22, 2019 | State referral letter | Referral Letter to the Minnesota State Board of Pharmacy Issued 10/22/2019 | FDA copy (archived) |
| Oct 22, 2019 | FMD-145 letter | FMD-145 Letter Issued 10/22/2019 | FDA copy (archived) |
An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists W & C, Sartell, MN (FEI number 3012360920), matched to this page by exact name, city and state. It lists 1 inspection: 1 OAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jun 17, 2016 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3012360920 | 974329 |
Form 483s FDA has published for this site
- Jul 30, 2018: Form 483 to W & C, published Oct 2, 2019. fda.gov
- Aug 14, 2017: Form 483 to W & C, published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection dated Jul 30, 2018 by FDA (dates on the form not read): 1 observation
- Firm on the cover
- W&C Apothecary dba The Apothecary, 165 19th St. S, Ste 102, CODE
- FEI number
- 3012360920
- Establishment type on the cover
- Producer of non-sterile drugs Sartell, MN 56377-2567
- FDA district office on the cover
- 25
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.
Observation 1
You have procduced beta-lactam drugs and highly potent drugs without providing adequate cleaning of work su
rfaces and cleaning of utensils to prevent cross-contamination.
Specifically,
a. Your firm produced the following batches of ceftazidime:
Batch 03201710@12 on 10/04/2017, using <Redacted B4> h ood #1 Batch 23201801@11on 01/23/2018, using <Redact ed B4> hood #2 Batch 15201805@20 on 05/16/2018, using <
Redacted B4> hood #1 Ceftazidime powder was mixed with other powder excipients and encapsulated. These b atches were produced without adequate inactivation of the drug in the work area and on equipment us ed. Batcb records for 03201710@12 and 15201805@,,20 indicate that <Redacted B4> and <Redacted B4> were used during cleaning, while the batch recor d for 2 3201801@11 indicates that only <Redacted B4> was used during cleaning. Pharmacist-In-Charge <Redacted B4> stated to me that the· batches were made wi th equipment dedicated to non-hazardous drug products and thu s cleaning would have been performed with only <Redacted B4> stated that the batch records indicating that <Redacted B4> used during cleaning were inaccurate. ...
Linked 483s whose text is not shown
- Aug 14, 2017: FDA document 99021: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
State board of pharmacy records for Minnesota are not checked: the board’s website answers automated requests with a bot challenge, and this index does not work around blocks.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
Records last pulled Nov 15, 2026. Every entry links to the original public record.